MedPath

Treating refractory leg ulcers with autologous Platelet rich products

Phase 3
Completed
Conditions
Health Condition 1: L979- Non-pressure chronic ulcer of unspecified part of lower leg
Registration Number
CTRI/2020/04/024526
Lead Sponsor
Department of Dermatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
64
Inclusion Criteria

leg ulcers more than 8 weeks treatment not responding to conventional treatment, age more than 18 years

Exclusion Criteria

malignancy, burns, pregnency and lactating women, uncontrolled diabetes mellitus, coagulopathy including platelet less than 1.5 lakhs /mm3, willing patients on anticoagulants, not willing to give a valid written consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath